Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?

This publication has 130 references indexed in Scilit:

• GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation
  British Journal of Pharmacology, 2004
• AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
  Published by Elsevier ,2004
• Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
  The Lancet Oncology, 2004
• Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase
  Journal of Biological Chemistry, 2004
• 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-α production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages
  Biochemical and Biophysical Research Communications, 2004
• Thiazolidinediones increase arachidonic acid release and subsequent prostanoid production in a peroxisome proliferator-activated receptor γ-independent manner
  Prostaglandins & Other Lipid Mediators, 2004
• AICAR stimulates adiponectin and inhibits cytokines in adipose tissue
  Biochemical and Biophysical Research Communications, 2004
• Molecular characterisation of six alternatively spliced variants and a novel promoter in human peroxisome proliferator-activated receptor α
  Biochemical and Biophysical Research Communications, 2003
• Genetic analysis of four novel peroxisome proliferator activated receptor-γ splice variants in monkey macrophages
  Biochemical and Biophysical Research Communications, 2002
• Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways
  Free Radical Biology & Medicine, 1996